ArticleBlood cancer journal2024

Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy.

Danai Dima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.